Can Stroke Patients and Their Caregiver Benefit From Additive Mindfulness Training
NCT ID: NCT03271788
Last Updated: 2017-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
8 participants
INTERVENTIONAL
2017-12-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stroke Survivors and Caregivers Using an Online Mindfulness-based Intervention Together
NCT03473054
Stroke Of Mindfulness: Investigating Physiological and Psychological Well-being
NCT03659409
Effectiveness of Mindfulness After a Stroke
NCT05029193
Online Mindfulness for Stroke Sufferers
NCT03368950
Mindfulness After Stroke
NCT04553679
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Furthermore, we want to find out if Mindfulness has a positive impact towards the quality of life and the daily burden of stroke patients and their caregivers.
The overall purpose of this study is to evaluate the feasibility of the process-basis, resources-basis, management-basis, and scientific basis for a further larger study. We want to conduct an exploratory case study as an A-B Design in which the A-Phase is "only regular occupational therapy" (no additive intervention) and the B-Phase contains the "regular occupational therapy" and "MBSR" (Mindfulness-Course; intervention).
Four stroke patients and their closest relative will be included in the study (n=8).
The study is non-blinded and no randomised allocation will take place. We will compare the outcomes of Phase B with the outcomes of Phase A of every person.
The purpose of the exploratory case study is to analyse the feasibility of the study design that will be used in a subsequent research study.
The study will last 16 weeks; split into two parts of eight weeks (A Phase and B-Phase).
1. Baseline Measurement
If the patient and the caregivers are included into the study they perform several measurements and questionnaires:
* Measurements to assess physical capabilities (Patient)
* Measurement to assess attention (Patient)
* Measurements to assess Quality of life daily burden of illness and caregiving (Patient and Caregiver
* Semi structured Interviews (Patient and Caregiver)
2. A-Phase The stroke patient continues his/her regular occupational treatment for eight weeks.
The caregivers get no study-related treatment.
3. 2nd (Midterm)-Measurement Same procedure as the baseline measurement.
4. B-Phase (Intervention Phase) Within the B-Phase of the study, the participant gets Mindfulness Training (intervention) in addition to the regular occupational therapy.
Before Patients and Caregivers start the MBSR Course (Mindfulness) the get information from an experienced Mindfulness trainer about e.g. duration, contents of the course, etc. They have the opportunity to ask questions.
The course lasts eight weeks. The MBSR group meet every week for 2.5h. The participants will get "homework" that they to perform at home (1h per day). If the duration of practice is to burdensome for the participants, then they can talk to the MBSR-trainer about time reduction.
5. 3rd (Final) Measurement Same procedure as the baseline and second (Midterm-) measurement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
stroke patients and caregivers
Stroke patients will conduct two phases ( A-Phase: regular occupational therapy; B-Phase occupational therapy with additional mindfulness) Caregivers of the patients will conduct the MBSR Course (Mindfulness) together with their relatives (Phase B). In Phase A they will not receive any treatment.
Mindfulness, MBSR
Participants (stroke patients and one of their closest relatives) will conduct an MBSR Course in Phase B
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mindfulness, MBSR
Participants (stroke patients and one of their closest relatives) will conduct an MBSR Course in Phase B
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult stroke patients (outpatients) who gets regular occupational therapy
* Time after stroke at least 6 months
* Modified Rankin Scale ≥1≤ 4
* Mini Mental State ≥ 24
* Close relative who is primary in charge and bear the largest burden of the caregiving of the stroke patient
Exclusion Criteria
* Severe cognitive disorders
* Severe speech comprehension disorders
* Known or suspected drug, medication or alcohol abuse
* Inability to follow the procedures of the study, e.g. due to language
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zurich University of Applied Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Silke Neumann
Master of Science
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Silke Neumann, MSC
Role: PRINCIPAL_INVESTIGATOR
Zurich University of Applied Sciences
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
97106125033101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.